NCT01666717
Completed
Not Applicable
Characterization of Disease Related Changes in Inflammatory Bowel Disease Using Fecal Metabolite Profiling
ConditionsInflammatory Bowel Diseases
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Inflammatory Bowel Diseases
- Sponsor
- KU Leuven
- Enrollment
- 204
- Locations
- 1
- Status
- Completed
- Last Updated
- 13 years ago
Overview
Brief Summary
The purpose of the study is to evaluate fecal metabolites profiles of Inflammatory Bowel Disease(IBD) patients versus healthy controls (HC).
Investigators
Kristin Verbeke
Professor K. Verbeke
KU Leuven
Eligibility Criteria
Inclusion Criteria
- •Clinical diagnosis of IBD
- •Age \>18 years
Exclusion Criteria
- •Use of antibiotics in the preceding month
- •Intake of pre- or probiotics
Outcomes
Primary Outcomes
Not specified
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Metabolomic Analysis, a Potential Tool to Direct Treatment With Adalimumab in Crohn's Disease (CD)Crohn's DiseaseNCT01105741Martin Storr25
Not yet recruiting
Not Applicable
Inflammatory Marker in Ibd and Peripheral ArthritisIBD-Inflammatory Bowel DiseaseNCT05705232Assiut University150
Recruiting
Not Applicable
Metabolic Profiling of Inflammatory Bowel Disease in Children and AdolescentsK50K51K52Crohn disease [regional enteritis]Ulcerative colitisOther noninfective gastroenteritis and colitisDRKS00030960niversitätsklinikum Heidelberg, Klinik für Kinderheilkunde I200
Not yet recruiting
Not Applicable
Risk Factors and Impact MASLD in Patients With IBDMetabolic Dysfunction-associated Steatotic Liver DiseaseNCT06328452Assiut University120
Recruiting
Not Applicable
Advanced Therapy Registry of IBD PatientsCrohn DiseaseUlcerative ColitisPouchitisNCT04998084Tel-Aviv Sourasky Medical Center1,000